Cargando…
Improving treatment provision of Wet AMD with intravitreal ranibizumab
Wet age-related macular degeneration (AMD) treatment using intravitreal ranibizumab needs to be started as soon as possible and treatment must be administered based on regular review to achieve the best results. In clinical practice this tight schedule is a challenge and methods of carrying out such...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
British Publishing Group
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652712/ https://www.ncbi.nlm.nih.gov/pubmed/26734182 http://dx.doi.org/10.1136/bmjquality.u201733.w993 |